Yes, a man can absolutely have HPV without any symptoms. In fact, that’s the most common scenario. About one in three men over age 15 worldwide carry at least one type of genital HPV, and the vast majority of those infections produce no visible signs at all. Most men who have HPV will never know it unless they develop a rare complication years later.
Why Most HPV Infections Stay Silent
HPV is not one virus but a family of more than 200 related types. They fall into two broad categories: low-risk types that can cause genital warts, and high-risk types that can eventually lead to cancer. Neither category reliably produces symptoms in men. The low-risk types only cause visible warts in a fraction of those infected, and the high-risk types, carried by roughly one in five men globally, almost never announce themselves with any outward sign. A man can carry the virus on the skin of his genitals, in his anal area, or in his throat for months or years with nothing to see or feel.
The body’s immune system clears most HPV infections on its own. In men, the median time to clearance is about six months, and 75% of infections resolve within a year. Only about 6% of HPV-positive men develop a persistent infection, compared with 20% of women. That means the overwhelming pattern for men is: get infected, never notice, clear the virus, and move on without ever knowing it happened.
No Approved HPV Test Exists for Men
This is one of the most frustrating parts of the situation. There is no FDA-approved HPV test for men. HPV testing was developed for cervical screening in women, and no equivalent has been validated or approved for detecting the virus on the penis, anus, or throat. The CDC does not recommend routine HPV screening for men, partly because of this testing gap and partly because the infection is so common and usually clears without treatment.
Some providers have used a technique where diluted acetic acid is applied to genital skin, turning HPV-affected areas white. But this method is not recommended for routine use because the results don’t change clinical management. In practice, most men only learn they have HPV if visible warts appear or if a partner is diagnosed.
Transmission Happens Without Symptoms
A man doesn’t need to have warts or any other visible sign to pass HPV to a partner. The virus transmits through skin-to-skin contact during sexual activity, and it spreads efficiently even when the carrier has no idea they’re infected. Research tracking heterosexual couples found that HPV-positive men transmitted the virus to female partners at a rate of about 3.5 new infections per 100 person-months of exposure. That means over the course of a sexual relationship, the odds of passing it along are substantial, even with zero symptoms on either side.
Condoms reduce transmission but don’t eliminate it, because HPV can live on skin that a condom doesn’t cover. This is why HPV is the most common sexually transmitted infection in the world, with most sexually active people encountering it at some point.
The Cancer Risks Men Should Know About
The reason silent HPV infections matter is that high-risk strains, particularly HPV16 and HPV18, can persist in a small number of men and cause cancer years or even decades later. The cancers linked to HPV in men include oropharyngeal cancer (cancer of the back of the throat, base of the tongue, and tonsils), anal cancer, and penile cancer. The strains that cause warts are different from the strains that cause cancer, so the absence of warts says nothing about cancer risk.
Oropharyngeal cancer has become the most alarming HPV-related trend in men. In the United States, 70% to 80% of oropharyngeal cancers are now HPV-positive, and the number of these cancers increased by 225% between 1988 and 2004. HPV has overtaken tobacco and alcohol as the leading cause of throat cancer in several countries, with men disproportionately affected. These cancers typically show up in a man’s 40s, 50s, or 60s, long after the initial silent infection.
Anal cancer is less common overall but poses serious risk to certain groups. Men who have sex with men, especially those living with HIV, face rates exceeding 131 cases per 100,000 per year, comparable to cervical cancer rates before screening programs existed. Penile cancer is rare globally but is linked to HPV in about half of cases.
Screening for Higher-Risk Men
While routine HPV testing isn’t available for men, targeted cancer screening does exist for those at elevated risk. Current guidelines recommend anal cancer screening starting at age 35 for men who have sex with men and are living with HIV. For men who have sex with men without HIV, screening is recommended starting at age 45. These screenings look for precancerous cell changes in the anal canal, similar in concept to a cervical Pap test.
For oropharyngeal cancer, no routine screening protocol exists yet. Most cases are caught when a man notices a persistent sore throat, difficulty swallowing, a lump in the neck, or ear pain that doesn’t resolve. Dentists sometimes spot suspicious lesions during oral exams.
Vaccination Is the Best Protection
The HPV vaccine is the most effective tool for preventing infection before it happens. The CDC recommends two doses for children at ages 11 to 12, with the series starting as early as age 9. If the first dose is given before the 15th birthday, only two shots are needed, spaced 6 to 12 months apart. People who start the series at 15 or older need three doses spread over six months.
Vaccination is routinely recommended through age 26 for anyone not previously vaccinated. For adults between 27 and 45, it’s not a blanket recommendation, but it remains an option worth discussing based on individual risk. The vaccine is most effective when given before exposure to the virus, which is why the emphasis is on adolescents. But even for older men who have already been exposed to some HPV types, the vaccine can still protect against types they haven’t encountered.
The vaccine covers the high-risk types most likely to cause cancer (including HPV16 and HPV18) as well as the low-risk types responsible for most genital warts. For men who were never vaccinated as teenagers, catching up before 26 provides meaningful protection against the cancers that can develop silently from infections picked up years earlier.